Skip to content

Use of Kumkum Nasya and Pathyadi Shadanga Kwatha in the management of Ardhavabhedaka

A CLINICAL STUDY OF KUMKUM NASYA AND PATHYADI SHADANGA KWATHA IN THE MANAGEMENT OF ARDHAVABHEDAKA WITH SPECIAL REFERENCE TO MIGRAINE - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073659
Enrollment
60
Registered
2024-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Sponsors

GOVERNMENT PG AYURVEDA COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-PATIENTS AGED BETWEEN 18-70 YEARS IRRESPECTIVE OF THEIR GENDER 2-PATIENTS PRESENTING WITH SIGNS AND SYMPTOMS OF ARDHAVABHEDAKA (MIGRAINE)DESCRIBED AS PER AYURVEDIC AND MODERN LITERATURE 3-PATIENTS FIT FOR NASYA KARMA 4-PATIENTS WITH VATA PRADHAN LAKSHANA

Exclusion criteria

Exclusion criteria: 1-PATIENTS UNFIT FOR NASYA KARMA EG.BHUKTABHAKTA,AJIRNA,PITA SNEHA,PITA MADYA,PITA TOYA,SNATASIRA,KSHUDHARTA,SHRAMATA,MATTA,MURCCHITA,MANASOPAGHATA ETC. 2-PATIENT BELOW 18 AND ABOVE 70 ARE EXCLUDED. 3-PREGNANT AND LACTATING WOMEN. 4-PATIENTS WITH COMPLICATED MIGRAINE LIKE HEMIPLEGIC MIGRAINE,STATUS MIGRAINOSUS,OPHTHALMIC MIGRAINE,RETINAL MIGRAINE,BASILAR ARTERY MIGRAINE AND HAVING ANY CHRONIC DEBILITATING DISEASE WITH OTHER NEUROLOGICAL PATHOLOGY. 5-PATIENTS HAVING OTHER SHIROROGAS LIKE SHANKHAKA,SURYAVARTA,ANANTAVATA ETC,WILL BE EXCLUDED. 6-PATIENTS HAVING ANY IMMUNOCOMPROMISED E.G.TUBERCULOSIS,CANCER,DIABETES MELLITUS,HEART DISEASE,HYPERTENSION ETC. 7-SECONDARY HEADACHE CAUSED BY SINUS HEADACHE,MENINGITIS,ENCEPHALITIS,CERVICAL SPONDYLITIS,REFRACTIVE ERROR AND INCREASED INTRA OCULAR PRESSURE. 8-PATIENTS USING DRUGS FOR ANY OTHER SYSTEMIC ILLNESS WHICH INTERFERE WITH THE COURSE OF THE TREATMENT WILL BE ECXCLUDED. 9-PATIENTS HAVING ANY INFLAMMATORY DISEASES IN NOSE,PNS,EYES AND EARS,THROAT,TEETH ETC.

Design outcomes

Primary

MeasureTime frame
MILD RELIEF IN PAIN,VERTIGO,NAUSEA,VOMITINGTimepoint: 7 days

Secondary

MeasureTime frame
COMPLETE RESOLVE IN CHIEF COMPLAINTS OF MIGRAINETimepoint: 28 DAYS

Countries

India

Contacts

Public ContactDRAJAY KUMAR

GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL,VARANASI

drajay2000@gmail.com9616870871

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026